Skip to search formSkip to main contentSkip to account menu

heparin

Known as: Eparina, heparin unfractionated, Heparinate 
A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular… 
National Institutes of Health

Related topics

Related topics

48 relations

Narrower (20)

AVE 5026CalciparineDolo-RubrimentEssaven Gel

Broader (5)

AnticoagulantsAntithrombinsGlycosaminoglycansIndwelling Catheter
CatheterizationCoronary ThrombosisHeparin 10000 U per mL given:Vol:Pt:^Patient:QnHeparin 5000 U per mL given:Vol:Pt:^Patient:Qn

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
Heparin‐induced thrombocytopenia: pathogenesis and management
Heparin-induced thrombocytopenia (HIT) is a transient prothrombotic disorder initiated by heparin. Its central feature is… 
Highly Cited
1997
Highly Cited
1997
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group…
Background Antithrombotic therapy with heparin plus aspirin reduces the rate of ischemic events in patients with unstable… 
Highly Cited
1994
Highly Cited
1994
Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.
Sera of 34 patients with heparin-associated thrombocytopenia (HAT), giving a positive result in the serotonin release assay (SRA… 
Highly Cited
1992
Highly Cited
1992
Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia
Heparin-induced thrombocytopenia (HIT) remains a major complication of heparin therapy (1). Type I, where thrombocy­ topenia is… 
Highly Cited
1990
Highly Cited
1990
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site
Review
1989
Review
1989
The heparin-binding (fibroblast) growth factor family of proteins.
Highly Cited
1988
Highly Cited
1988
Aspirin, heparin, or both to treat acute unstable angina.
We tested the usefulness of aspirin (325 mg twice daily), heparin (1000 units per hour by intravenous infusion), and a… 
Highly Cited
1986
Highly Cited
1986
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
We performed a randomized double-blind trial comparing continuous intravenous heparin with intermittent subcutaneous heparin in… 
Highly Cited
1984
Highly Cited
1984
Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor.
A tumor-derived growth factor that stimulates the proliferation of capillary endothelial cells has a very strong affinity for… 
Highly Cited
1972
Highly Cited
1972
A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time.
Abstract Two hundred and thirty-four patients treated with continuous intravenous infusions of heparin were studied prospectively… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)